Clinical Trial Update: Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating long-term use of AIN457 for uveitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Uveitis | Phase 3 | Status: WITHDRAWN